Arbutus Biopharma

In News

Moderna Tells Fed. Circ. US Must Face COVID Vax Patent Case - Law360

Law360 - Jun 01, 2026

Shareholders at Arbutus Biopharma (NASDAQ: ABUS) approve 2026 share plan and auditor - Stock Titan

Stock Titan - May 27, 2026

ABUS Stock Price, Quote & Chart | ARBUTUS BIOPHARMA CORP (NASDAQ:ABUS) - ChartMill

ChartMill - May 28, 2026

Arbutus Biopharma (ABUS): 10 Best Biotech Penny Stocks to Buy in 2026 - Yahoo Finance

Yahoo Finance - May 01, 2026

Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences - European AIDS Treatment Group

European AIDS Treatment Group - Apr 15, 2026

Arbutus Biopharma earnings beat by $0.91, revenue topped estimates - Investing.com

Investing.com - May 13, 2026

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna - GlobeNewswire

GlobeNewswire - Mar 03, 2026

Arbutus Biopharma: A Fascinating HBV Story, But Still Too Early (NASDAQ:ABUS) - Seeking Alpha

Seeking Alpha - May 13, 2026

Arbutus Biopharma Corp ($ABUS) Former Interim President and CEO 2025 Pay Revealed - Quiver Quantitative

Quiver Quantitative - Apr 15, 2026

Arbutus Biopharma Q1 revenue surges on Moderna settlement - TradingView

TradingView - May 13, 2026

Judge Wolson Issues Key Summary Judgment Ruling on the Eve of Trial in the Arbutus v. Moderna mRNA Vaccine and Lipid Nanoparticle Case - JD Supra

JD Supra - Feb 05, 2026

Arbutus Biopharma Stock Pre-Market (-9.4%): Post-Settlement Profit Taking - Trefis

Trefis - Mar 04, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment